Study design (if review, criteria of inclusion for studies)
Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment
Participants
Cystic Fibrosis|Abdominal Pain|Small Bowel Disease - 12 Years and older (Child, Adult, Older Adult)
Interventions
Drug: Rifaximin 550 MG Oral Tablet [XIFAXAN]|Drug: Placebo
Outcome measures
Rifaximin Treatment Group Improvement of Symptoms|Improved ePROS scores